nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP3A4—Thiotepa—urinary bladder cancer	0.173	0.386	CbGbCtD
Ramelteon—CYP1A2—Fluorouracil—urinary bladder cancer	0.108	0.239	CbGbCtD
Ramelteon—CYP1A2—Etoposide—urinary bladder cancer	0.0897	0.2	CbGbCtD
Ramelteon—CYP3A4—Etoposide—urinary bladder cancer	0.047	0.105	CbGbCtD
Ramelteon—CYP3A4—Doxorubicin—urinary bladder cancer	0.0321	0.0713	CbGbCtD
Ramelteon—Myalgia—Valrubicin—urinary bladder cancer	0.008	0.0342	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.00699	0.0299	CcSEcCtD
Ramelteon—Asthenia—Valrubicin—urinary bladder cancer	0.00551	0.0235	CcSEcCtD
Ramelteon—Diarrhoea—Valrubicin—urinary bladder cancer	0.00525	0.0224	CcSEcCtD
Ramelteon—Dizziness—Valrubicin—urinary bladder cancer	0.00507	0.0217	CcSEcCtD
Ramelteon—Headache—Valrubicin—urinary bladder cancer	0.00481	0.0205	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.0047	0.0201	CcSEcCtD
Ramelteon—Somnolence—Mitomycin—urinary bladder cancer	0.0047	0.0201	CcSEcCtD
Ramelteon—Nausea—Valrubicin—urinary bladder cancer	0.00456	0.0195	CcSEcCtD
Ramelteon—Fatigue—Mitomycin—urinary bladder cancer	0.00456	0.0195	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.00438	0.0187	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00401	0.0171	CcSEcCtD
Ramelteon—Influenza—Gemcitabine—urinary bladder cancer	0.00393	0.0168	CcSEcCtD
Ramelteon—Asthenia—Mitomycin—urinary bladder cancer	0.00379	0.0162	CcSEcCtD
Ramelteon—Diarrhoea—Mitomycin—urinary bladder cancer	0.00362	0.0154	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Fluorouracil—urinary bladder cancer	0.00359	0.0153	CcSEcCtD
Ramelteon—Dizziness—Mitomycin—urinary bladder cancer	0.0035	0.0149	CcSEcCtD
Ramelteon—Headache—Mitomycin—urinary bladder cancer	0.00331	0.0141	CcSEcCtD
Ramelteon—Thinking abnormal—Epirubicin—urinary bladder cancer	0.00328	0.014	CcSEcCtD
Ramelteon—Nausea—Mitomycin—urinary bladder cancer	0.00314	0.0134	CcSEcCtD
Ramelteon—Thinking abnormal—Doxorubicin—urinary bladder cancer	0.00303	0.013	CcSEcCtD
Ramelteon—Myalgia—Thiotepa—urinary bladder cancer	0.00277	0.0118	CcSEcCtD
Ramelteon—Arthralgia—Thiotepa—urinary bladder cancer	0.00277	0.0118	CcSEcCtD
Ramelteon—Mental disability—Epirubicin—urinary bladder cancer	0.0026	0.0111	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00242	0.0103	CcSEcCtD
Ramelteon—Mental disability—Doxorubicin—urinary bladder cancer	0.00241	0.0103	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.0024	0.0103	CcSEcCtD
Ramelteon—Somnolence—Thiotepa—urinary bladder cancer	0.00236	0.0101	CcSEcCtD
Ramelteon—Myalgia—Gemcitabine—urinary bladder cancer	0.00233	0.00996	CcSEcCtD
Ramelteon—Arthralgia—Gemcitabine—urinary bladder cancer	0.00233	0.00996	CcSEcCtD
Ramelteon—Myalgia—Fluorouracil—urinary bladder cancer	0.00229	0.0098	CcSEcCtD
Ramelteon—Fatigue—Thiotepa—urinary bladder cancer	0.00229	0.00979	CcSEcCtD
Ramelteon—Dysgeusia—Etoposide—urinary bladder cancer	0.00229	0.00979	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00225	0.00961	CcSEcCtD
Ramelteon—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00224	0.00955	CcSEcCtD
Ramelteon—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.0022	0.00939	CcSEcCtD
Ramelteon—Myalgia—Cisplatin—urinary bladder cancer	0.00217	0.00929	CcSEcCtD
Ramelteon—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00208	0.0089	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00208	0.00889	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00204	0.0087	CcSEcCtD
Ramelteon—Insomnia—Gemcitabine—urinary bladder cancer	0.00202	0.00864	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.002	0.00856	CcSEcCtD
Ramelteon—Insomnia—Fluorouracil—urinary bladder cancer	0.00199	0.00849	CcSEcCtD
Ramelteon—Somnolence—Gemcitabine—urinary bladder cancer	0.00199	0.00849	CcSEcCtD
Ramelteon—Somnolence—Fluorouracil—urinary bladder cancer	0.00195	0.00835	CcSEcCtD
Ramelteon—Fatigue—Gemcitabine—urinary bladder cancer	0.00193	0.00824	CcSEcCtD
Ramelteon—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00191	0.00816	CcSEcCtD
Ramelteon—Asthenia—Thiotepa—urinary bladder cancer	0.00191	0.00815	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.0019	0.00811	CcSEcCtD
Ramelteon—Influenza—Epirubicin—urinary bladder cancer	0.00188	0.00804	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00187	0.00798	CcSEcCtD
Ramelteon—Diarrhoea—Thiotepa—urinary bladder cancer	0.00182	0.00777	CcSEcCtD
Ramelteon—Depression—Methotrexate—urinary bladder cancer	0.00179	0.00764	CcSEcCtD
Ramelteon—Dizziness—Thiotepa—urinary bladder cancer	0.00176	0.00751	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00175	0.00747	CcSEcCtD
Ramelteon—Influenza—Doxorubicin—urinary bladder cancer	0.00174	0.00744	CcSEcCtD
Ramelteon—Somnolence—Etoposide—urinary bladder cancer	0.0017	0.00725	CcSEcCtD
Ramelteon—Headache—Thiotepa—urinary bladder cancer	0.00167	0.00711	CcSEcCtD
Ramelteon—Fatigue—Etoposide—urinary bladder cancer	0.00165	0.00703	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00162	0.00691	CcSEcCtD
Ramelteon—Asthenia—Gemcitabine—urinary bladder cancer	0.0016	0.00685	CcSEcCtD
Ramelteon—Nausea—Thiotepa—urinary bladder cancer	0.00158	0.00674	CcSEcCtD
Ramelteon—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00153	0.00654	CcSEcCtD
Ramelteon—Diarrhoea—Fluorouracil—urinary bladder cancer	0.0015	0.00643	CcSEcCtD
Ramelteon—Asthenia—Cisplatin—urinary bladder cancer	0.0015	0.00639	CcSEcCtD
Ramelteon—Dizziness—Fluorouracil—urinary bladder cancer	0.00145	0.00621	CcSEcCtD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00143	0.00452	CbGpPWpGaD
Ramelteon—Diarrhoea—Cisplatin—urinary bladder cancer	0.00143	0.00609	CcSEcCtD
Ramelteon—MTNR1B—Circadian rythm related genes—PTEN—urinary bladder cancer	0.00142	0.00449	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—PTEN—urinary bladder cancer	0.00142	0.00449	CbGpPWpGaD
Ramelteon—Headache—Gemcitabine—urinary bladder cancer	0.0014	0.00598	CcSEcCtD
Ramelteon—MTNR1A—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.00139	0.00441	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CXCL8—urinary bladder cancer	0.00139	0.00441	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.00139	0.0044	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.00139	0.0044	CbGpPWpGaD
Ramelteon—Headache—Fluorouracil—urinary bladder cancer	0.00138	0.00588	CcSEcCtD
Ramelteon—Dysgeusia—Methotrexate—urinary bladder cancer	0.00137	0.00586	CcSEcCtD
Ramelteon—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.00137	0.00434	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.00137	0.00434	CbGpPWpGaD
Ramelteon—Asthenia—Etoposide—urinary bladder cancer	0.00137	0.00585	CcSEcCtD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00135	0.00428	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—EP300—urinary bladder cancer	0.00135	0.00428	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—EP300—urinary bladder cancer	0.00135	0.00428	CbGpPWpGaD
Ramelteon—Nausea—Gemcitabine—urinary bladder cancer	0.00133	0.00567	CcSEcCtD
Ramelteon—Diarrhoea—Etoposide—urinary bladder cancer	0.00131	0.00558	CcSEcCtD
Ramelteon—Nausea—Fluorouracil—urinary bladder cancer	0.00131	0.00558	CcSEcCtD
Ramelteon—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.00129	0.00407	CbGpPWpGaD
Ramelteon—Dysgeusia—Epirubicin—urinary bladder cancer	0.00128	0.00549	CcSEcCtD
Ramelteon—Dizziness—Etoposide—urinary bladder cancer	0.00126	0.00539	CcSEcCtD
Ramelteon—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.00126	0.00397	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HDAC4—urinary bladder cancer	0.00125	0.00395	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HDAC4—urinary bladder cancer	0.00125	0.00395	CbGpPWpGaD
Ramelteon—Nausea—Cisplatin—urinary bladder cancer	0.00124	0.00529	CcSEcCtD
Ramelteon—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00124	0.00392	CbGpPWpGaD
Ramelteon—CYP2C19—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00123	0.00388	CbGpPWpGaD
Ramelteon—Headache—Etoposide—urinary bladder cancer	0.0012	0.00511	CcSEcCtD
Ramelteon—Myalgia—Methotrexate—urinary bladder cancer	0.00119	0.0051	CcSEcCtD
Ramelteon—Arthralgia—Methotrexate—urinary bladder cancer	0.00119	0.0051	CcSEcCtD
Ramelteon—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00119	0.00508	CcSEcCtD
Ramelteon—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00114	0.00489	CcSEcCtD
Ramelteon—Nausea—Etoposide—urinary bladder cancer	0.00113	0.00484	CcSEcCtD
Ramelteon—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.00113	0.00357	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.00112	0.00353	CbGpPWpGaD
Ramelteon—Myalgia—Epirubicin—urinary bladder cancer	0.00112	0.00477	CcSEcCtD
Ramelteon—Arthralgia—Epirubicin—urinary bladder cancer	0.00112	0.00477	CcSEcCtD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00111	0.00353	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.00111	0.0035	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.00111	0.0035	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.0011	0.00349	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00107	0.00457	CcSEcCtD
Ramelteon—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00106	0.00335	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00106	0.00335	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GLI1—urinary bladder cancer	0.00105	0.00331	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GLI1—urinary bladder cancer	0.00105	0.00331	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00104	0.0033	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00104	0.00445	CcSEcCtD
Ramelteon—Insomnia—Methotrexate—urinary bladder cancer	0.00103	0.00442	CcSEcCtD
Ramelteon—Arthralgia—Doxorubicin—urinary bladder cancer	0.00103	0.00441	CcSEcCtD
Ramelteon—Myalgia—Doxorubicin—urinary bladder cancer	0.00103	0.00441	CcSEcCtD
Ramelteon—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.00103	0.00325	CbGpPWpGaD
Ramelteon—Somnolence—Methotrexate—urinary bladder cancer	0.00102	0.00434	CcSEcCtD
Ramelteon—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000997	0.00315	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00099	0.00423	CcSEcCtD
Ramelteon—Fatigue—Methotrexate—urinary bladder cancer	0.000986	0.00421	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000975	0.00417	CcSEcCtD
Ramelteon—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000974	0.00308	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000969	0.00306	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—TP53—urinary bladder cancer	0.000969	0.00306	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—TP53—urinary bladder cancer	0.000969	0.00306	CbGpPWpGaD
Ramelteon—Insomnia—Epirubicin—urinary bladder cancer	0.000968	0.00414	CcSEcCtD
Ramelteon—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.000965	0.00305	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000956	0.00302	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000955	0.00302	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000952	0.00301	CbGpPWpGaD
Ramelteon—Somnolence—Epirubicin—urinary bladder cancer	0.000952	0.00406	CcSEcCtD
Ramelteon—Fatigue—Epirubicin—urinary bladder cancer	0.000923	0.00394	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000902	0.00385	CcSEcCtD
Ramelteon—Insomnia—Doxorubicin—urinary bladder cancer	0.000896	0.00383	CcSEcCtD
Ramelteon—Somnolence—Doxorubicin—urinary bladder cancer	0.000881	0.00376	CcSEcCtD
Ramelteon—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000872	0.00276	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00086	0.00272	CbGpPWpGaD
Ramelteon—Fatigue—Doxorubicin—urinary bladder cancer	0.000854	0.00365	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000843	0.00267	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000843	0.00267	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000838	0.00265	CbGpPWpGaD
Ramelteon—Asthenia—Methotrexate—urinary bladder cancer	0.000821	0.00351	CcSEcCtD
Ramelteon—Diarrhoea—Methotrexate—urinary bladder cancer	0.000783	0.00334	CcSEcCtD
Ramelteon—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000772	0.00244	CbGpPWpGaD
Ramelteon—Asthenia—Epirubicin—urinary bladder cancer	0.000768	0.00328	CcSEcCtD
Ramelteon—Dizziness—Methotrexate—urinary bladder cancer	0.000756	0.00323	CcSEcCtD
Ramelteon—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000752	0.00238	CbGpPWpGaD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000751	0.00238	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000748	0.00237	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000742	0.00235	CbGpPWpGaD
Ramelteon—Diarrhoea—Epirubicin—urinary bladder cancer	0.000732	0.00313	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000732	0.00231	CbGpPWpGaD
Ramelteon—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000722	0.00228	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RBX1—urinary bladder cancer	0.000717	0.00227	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RBX1—urinary bladder cancer	0.000717	0.00227	CbGpPWpGaD
Ramelteon—Headache—Methotrexate—urinary bladder cancer	0.000717	0.00306	CcSEcCtD
Ramelteon—Asthenia—Doxorubicin—urinary bladder cancer	0.000711	0.00304	CcSEcCtD
Ramelteon—Dizziness—Epirubicin—urinary bladder cancer	0.000708	0.00302	CcSEcCtD
Ramelteon—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000691	0.00218	CbGpPWpGaD
Ramelteon—Nausea—Methotrexate—urinary bladder cancer	0.000679	0.0029	CcSEcCtD
Ramelteon—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000678	0.00289	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—TSC1—urinary bladder cancer	0.000675	0.00213	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TSC1—urinary bladder cancer	0.000675	0.00213	CbGpPWpGaD
Ramelteon—Headache—Epirubicin—urinary bladder cancer	0.000671	0.00286	CcSEcCtD
Ramelteon—Dizziness—Doxorubicin—urinary bladder cancer	0.000655	0.0028	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—JAG1—urinary bladder cancer	0.000642	0.00203	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—JAG1—urinary bladder cancer	0.000642	0.00203	CbGpPWpGaD
Ramelteon—Nausea—Epirubicin—urinary bladder cancer	0.000636	0.00272	CcSEcCtD
Ramelteon—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000635	0.00201	CbGpPWpGaD
Ramelteon—Headache—Doxorubicin—urinary bladder cancer	0.00062	0.00265	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000601	0.0019	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000601	0.0019	CbGpPWpGaD
Ramelteon—Nausea—Doxorubicin—urinary bladder cancer	0.000588	0.00251	CcSEcCtD
Ramelteon—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000583	0.00184	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.00058	0.00184	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000572	0.00181	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000563	0.00178	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000557	0.00176	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000557	0.00176	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000543	0.00172	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000543	0.00172	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000526	0.00166	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—S100B—urinary bladder cancer	0.00052	0.00164	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—S100B—urinary bladder cancer	0.00052	0.00164	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000519	0.00164	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000512	0.00162	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.0005	0.00158	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.0005	0.00158	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—RHOA—urinary bladder cancer	0.000493	0.00156	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—RHOA—urinary bladder cancer	0.000493	0.00156	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000486	0.00154	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000486	0.00154	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000477	0.00151	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000477	0.00151	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000477	0.00151	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00047	0.00149	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NCOR1—urinary bladder cancer	0.000468	0.00148	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NCOR1—urinary bladder cancer	0.000468	0.00148	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000464	0.00147	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—IL2—urinary bladder cancer	0.000455	0.00144	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—IL2—urinary bladder cancer	0.000455	0.00144	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.00045	0.00142	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000436	0.00138	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000434	0.00137	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000433	0.00137	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000433	0.00137	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000426	0.00135	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000426	0.00135	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL2—urinary bladder cancer	0.000414	0.00131	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL2—urinary bladder cancer	0.000414	0.00131	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TERT—urinary bladder cancer	0.000412	0.0013	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TERT—urinary bladder cancer	0.000412	0.0013	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000406	0.00128	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000406	0.00128	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000404	0.00128	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000403	0.00127	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000399	0.00126	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—FGFR3—urinary bladder cancer	0.000378	0.0012	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—FGFR3—urinary bladder cancer	0.000378	0.0012	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000371	0.00117	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ESR1—urinary bladder cancer	0.000367	0.00116	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ESR1—urinary bladder cancer	0.000367	0.00116	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000366	0.00116	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000342	0.00108	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CREBBP—urinary bladder cancer	0.000322	0.00102	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CREBBP—urinary bladder cancer	0.000322	0.00102	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF1—urinary bladder cancer	0.000318	0.00101	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF1—urinary bladder cancer	0.000318	0.00101	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000318	0.001	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—EGFR—urinary bladder cancer	0.000316	0.001	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EGFR—urinary bladder cancer	0.000316	0.001	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000312	0.000986	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000308	0.000973	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000301	0.000953	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000301	0.000953	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—KRAS—urinary bladder cancer	0.000299	0.000945	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—KRAS—urinary bladder cancer	0.000299	0.000945	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000296	0.000937	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RHOA—urinary bladder cancer	0.000291	0.000921	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RHOA—urinary bladder cancer	0.000291	0.000921	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000287	0.000907	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000283	0.000894	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	0.000276	0.000871	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ERBB2—urinary bladder cancer	0.00027	0.000853	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ERBB2—urinary bladder cancer	0.00027	0.000853	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCL8—urinary bladder cancer	0.000256	0.000809	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCL8—urinary bladder cancer	0.000256	0.000809	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HRAS—urinary bladder cancer	0.000254	0.000803	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HRAS—urinary bladder cancer	0.000254	0.000803	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	0.000248	0.000785	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000248	0.000783	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL2—urinary bladder cancer	0.000244	0.000773	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL2—urinary bladder cancer	0.000244	0.000773	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCND1—urinary bladder cancer	0.000238	0.000753	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCND1—urinary bladder cancer	0.000238	0.000753	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	0.000235	0.000742	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NAT1—urinary bladder cancer	0.000235	0.000742	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	0.000234	0.000741	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MMP9—urinary bladder cancer	0.000231	0.000731	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MMP9—urinary bladder cancer	0.000231	0.000731	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000231	0.00073	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDKN1A—urinary bladder cancer	0.00023	0.000729	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	0.00023	0.000729	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTEN—urinary bladder cancer	0.00023	0.000727	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTEN—urinary bladder cancer	0.00023	0.000727	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	0.000228	0.000722	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EP300—urinary bladder cancer	0.000219	0.000693	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EP300—urinary bladder cancer	0.000219	0.000693	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000215	0.000679	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SRC—urinary bladder cancer	0.000213	0.000674	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SRC—urinary bladder cancer	0.000213	0.000674	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	0.000193	0.000611	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	0.000191	0.000604	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MYC—urinary bladder cancer	0.000191	0.000604	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MYC—urinary bladder cancer	0.000191	0.000604	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EGFR—urinary bladder cancer	0.000187	0.000591	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EGFR—urinary bladder cancer	0.000187	0.000591	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000183	0.000579	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	0.000183	0.000577	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TYMP—urinary bladder cancer	0.000183	0.000577	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	0.000181	0.000573	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NAT1—urinary bladder cancer	0.000181	0.000573	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	0.000178	0.000563	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KRAS—urinary bladder cancer	0.000177	0.000558	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KRAS—urinary bladder cancer	0.000177	0.000558	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000175	0.000554	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	0.000166	0.000524	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NAT2—urinary bladder cancer	0.000165	0.000522	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—urinary bladder cancer	0.000157	0.000496	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—urinary bladder cancer	0.000157	0.000496	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HRAS—urinary bladder cancer	0.00015	0.000475	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HRAS—urinary bladder cancer	0.00015	0.000475	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	0.000149	0.000472	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000143	0.000451	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—RRM2—urinary bladder cancer	0.000142	0.000451	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TYMP—urinary bladder cancer	0.000142	0.00045	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	0.000141	0.000446	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	0.000137	0.000434	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000137	0.000432	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	0.000132	0.000417	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ENO2—urinary bladder cancer	0.000132	0.000417	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000131	0.000415	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NAT2—urinary bladder cancer	0.000129	0.000407	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	0.000128	0.000405	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000126	0.000399	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—RRM2—urinary bladder cancer	0.000111	0.000351	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TYMP—urinary bladder cancer	0.00011	0.000347	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NQO1—urinary bladder cancer	0.000106	0.000336	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000103	0.000326	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	0.000103	0.000325	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ENO2—urinary bladder cancer	0.000103	0.000325	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000102	0.000323	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	9.97e-05	0.000315	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NAT2—urinary bladder cancer	9.92e-05	0.000314	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.82e-05	0.000311	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9e-05	0.000285	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	8.87e-05	0.000281	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.58e-05	0.000271	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.57e-05	0.000271	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NQO1—urinary bladder cancer	8.29e-05	0.000262	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TYMS—urinary bladder cancer	8.25e-05	0.000261	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	8.15e-05	0.000258	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	8.15e-05	0.000258	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.04e-05	0.000254	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.93e-05	0.000251	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.93e-05	0.000251	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GPX1—urinary bladder cancer	7.81e-05	0.000247	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.7e-05	0.000243	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	7.66e-05	0.000242	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	7.2e-05	0.000228	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.01e-05	0.000222	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	6.91e-05	0.000219	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.69e-05	0.000211	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TYMS—urinary bladder cancer	6.43e-05	0.000203	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.4e-05	0.000202	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	6.35e-05	0.000201	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	6.35e-05	0.000201	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GPX1—urinary bladder cancer	6.08e-05	0.000192	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	5.97e-05	0.000189	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPARG—urinary bladder cancer	5.84e-05	0.000185	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	5.61e-05	0.000178	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	5.61e-05	0.000177	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.33e-05	0.000169	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.96e-05	0.000157	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.9e-05	0.000155	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.9e-05	0.000155	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.69e-05	0.000148	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.61e-05	0.000146	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	4.6e-05	0.000145	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.55e-05	0.000144	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.37e-05	0.000138	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.33e-05	0.000137	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTEN—urinary bladder cancer	4.01e-05	0.000127	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—EP300—urinary bladder cancer	3.82e-05	0.000121	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.58e-05	0.000113	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.51e-05	0.000111	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.37e-05	0.000107	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.12e-05	9.88e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.98e-05	9.42e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.76e-05	8.74e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.41e-05	7.62e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.3e-05	7.27e-05	CbGpPWpGaD
